Unosi

• SAT0152 A Randomised,Doble-Blind ,Phase III Study Comparing SB2,An Infliximab Biosimilar, To the Infliximab Reference Product (Remicade) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (2015-06)

  J. Choe, N. Prodanović, j. Niebrizidovski, i. Staykov, E. Dokoupilova, A. Baranauskaite, R. Yatsyshyn, M. Mekić, W. Porawska, H. Ciferska, K. Jedrichovicz-Rosiak, A. Zielinska, J. Choe, Y. Rho, J. Smolen, SAT0152 A Randomised,Doble-Blind ,Phase III Study Comparing SB2,An Infliximab Biosimilar, To the Infliximab Reference Product (Remicade) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, Jun, 2015

• FRIO162 Comparable Safety and Immunogenecity and Sustained Efficacy after Transition To SB2 (An Infliximab Biosimilar) vs Ongoing Infliximab Reference Product In Patients with Rheumatoid Arthritis: Results of Phase III Transition Stud (2016)

  J. Smolen, J. Choe, N. Prodanović, I. Staykov, E. Dokoupilova, A. Baranauskaite, R. Yatsyshyn, M. Mekić, W. Porawska, H. Ciferska, K. Jedrichovicz-Rosiak, A. Zelinska, Z. Lee, Y. Rho, FRIO162 Comparable Safety and Immunogenecity and Sustained Efficacy after Transition To SB2 (An Infliximab Biosimilar) vs Ongoing Infliximab Reference Product In Patients with Rheumatoid Arthritis: Results of Phase III Transition Stud, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2016

• Efficacy and safety of CT- P13 (biosimilar infliximab) in patients with rheumatoid arthritis :Comparison betwen switching from reference infliximab to CT-P13 and continuing CT- P13 in the PLANETRA extension study (2016)

  D. Yoo, N. Prodanović, J. Jaworski, P. Miranda, E. Ramiterre, A. Lanzon, A. Baranauskaite, P. Wiland, C. Abud-Mendoza, B. Oparanov, S. Smiyan, H. Kim, S. Lee, S. Kim, W. Park, Efficacy and safety of CT- P13 (biosimilar infliximab) in patients with rheumatoid arthritis :Comparison betwen switching from reference infliximab to CT-P13 and continuing CT- P13 in the PLANETRA extension study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2016

• Skeletal muscle status and its prognostic role in men with heart failure with reduced ejection fraction (Meeting Abstract) (2016)

  G. Lončar, B. Božić, S. Healing, N. Prodanović, V. Popović-Brkić, Skeletal muscle status and its prognostic role in men with heart failure with reduced ejection fraction (Meeting Abstract), EUROPEAN HEART JOURNAL, pp. 10 - 10, 2016

• 3. Safety, immunogenecity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis:Results of a randomised, double-blind, phase III transation study (2017)

  J. Smolen, J. Choe, N. Prodanović, Y. Rho, 3. Safety, immunogenecity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis:Results of a randomised, double-blind, phase III transation study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2017

• Comparing biosimilar SB2 with reference infiximab after 54 weeks of a double-bilind trail:Clinical, structural and safety results (2017)

  J. Smolen, J. Choe, N. Prodanović, J. Niebrizidovski, I. Staikov, E. Dokoupilova, A. Baranauskaite, R. Iatsishin, M. Mekić, V. Poravska, H. Ciferska, K. Jedrichovicz-Rosiak, A. Zelinska, I. Lee, I. Rho, Comparing biosimilar SB2 with reference infiximab after 54 weeks of a double-bilind trail:Clinical, structural and safety results, RHEUMATOLOGY, pp. 10 - 10, 2017

• Androgen status in non-diabetic elderly men with heart failure (2017)

  G. Lončar, B. Božić, A. N, S. Nešković, N. Prodanović, V. Popović-Brkić, Androgen status in non-diabetic elderly men with heart failure, AGING MALE, pp. 10 - 10, 2017

• P162 Prognostic implication of body composition compartments and markers of its metabolism in noncechectic men with chronic heart failure (2017-08)

  G. Lončar, B. Božić, N. Cvetinović, N. Prodanović, V. Popović, P162 Prognostic implication of body composition compartments and markers of its metabolism in noncechectic men with chronic heart failure, EUROPEAN HEART JOURNAL, pp. 10 - 10, Aug, 2017

• Association of biomarkers of inflammation and HLA-DRB! Gene locus with risk of developing rheumatoid arthritis in females (2019)

  B. Krneta, H. Nefić, N. Prodanović, F. Hukić, Association of biomarkers of inflammation and HLA-DRB! Gene locus with risk of developing rheumatoid arthritis in females, RHEUMATOLOGY INTERNATIONAL, pp. 10 - 10, 2019

• A case report of a patient with features of systemic lupus erythematosus, lupus nephritis and syndrome Steven-Johansen/Leyll (2002)

  N. Prodanović, B. Božić, L. Rackov, L. Arsić, O. Marinković, Z. Anđelković, A case report of a patient with features of systemic lupus erythematosus, lupus nephritis and syndrome Steven-Johansen/Leyll, 2002

• Triamcinolone hexacetonide therapy compared to nimesulid in knee osteoarthritis (2002)

  N. Prodanović, B. Božić, L. Rackov, L. Arsić, R. Popović, I. Zgradić, Triamcinolone hexacetonide therapy compared to nimesulid in knee osteoarthritis, 2002

• „Markeri koštanog metabolizma i BMD u proceni uspešnosti terapije postmenopoauzalne osteoporoze Trisekvensom (2002)

  N. Prodanović, b. Božić, l. Rackov, l. Arsić, r. Popović, I. Zgradić, „Markeri koštanog metabolizma i BMD u proceni uspešnosti terapije postmenopoauzalne osteoporoze Trisekvensom, 2002

• Kombinovana primena metotreksata i arave u lečenju teških refraktarnih formi reumatoidnog artritisa (2003)

  N. Prodanović, B. Božić, R. Popović, I. Zgradić, Kombinovana primena metotreksata i arave u lečenju teških refraktarnih formi reumatoidnog artritisa, 2003

• Methotrexate treatment in combination with arava in pathients with severe refractory rheumatoid arthritis (2003)

  N. Prodanović, B. Božić, R. Popović, I. Zgradić, Methotrexate treatment in combination with arava in pathients with severe refractory rheumatoid arthritis, 2003

• Bone markers and BMD used to estimate the success rate of postmenopausal osteoporosis treatment with fosamax (2003)

  N. Prodanović, B. Božić, L. Rackov, L. Arsić, I. Zgradić, Bone markers and BMD used to estimate the success rate of postmenopausal osteoporosis treatment with fosamax, 2003

• The role of bone mineral measurment with gonarthritis (2003)

  N. Prodanović, B. Božić, J. Vasić, I. Zgradić, The role of bone mineral measurment with gonarthritis, 2003

• Correlation between radiogarphic satges of gonarthritis and bone mineral density (2003)

  N. Prodanović, B. Božić, I. Zgradić, Correlation between radiogarphic satges of gonarthritis and bone mineral density, 2003

• Percent of some risk factors with women in different radiographic stages of gonarthritis (2003)

  N. Prodanović, B. Božić, I. Zgradić, Percent of some risk factors with women in different radiographic stages of gonarthritis, 2003

• Udruženost ankilozirajućeg spondilitzisa i reumatoindog artritisa (2003)

  N. Prodanović, B. Božić, L. Rackov, L. Arsić, Udruženost ankilozirajućeg spondilitzisa i reumatoindog artritisa, 2003

• Povezanost radiografskih stadijuma gonarthritisa i nivoa koštane gustine (2003)

  N. Prodanović, B. Božić, I. Zgradić, Povezanost radiografskih stadijuma gonarthritisa i nivoa koštane gustine, 2003